High-Throughput Sequencing of mGluR Signaling Pathway Genes Reveals Enrichment of Rare Variants in Autism
暂无分享,去创建一个
Robert Pinard | H. Hovhannisyan | D. Margulies | U. Geigenmüller | R. Carpenter | Raymond J. Kelleher III | Ute Geigenmüller | Hayk Hovhannisyan | Edwin Trautman | Barbara Rathmell | Randall Carpenter | David Margulies | Randall L. Carpenter | R. Pinard | B. Rathmell | E. Trautman
[1] Murat Gunel,et al. Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome , 2005, Science.
[2] Kenny Q. Ye,et al. Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.
[3] K. M. Huber,et al. Homer Interactions Are Necessary for Metabotropic Glutamate Receptor-Induced Long-Term Depression and Translational Activation , 2008, The Journal of Neuroscience.
[4] D. Cooper,et al. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview , 2006, Human Genetics.
[5] J Andrew McCammon,et al. A novel switch region regulates H‐ras membrane orientation and signal output , 2008, The EMBO journal.
[6] Boris Yamrom,et al. Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.
[7] M. Rieder,et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.
[8] Ute Moog,et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation , 2010, Nature Genetics.
[9] Michael Wigler,et al. Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses , 2011, Neuron.
[10] Hyejin Kang,et al. Translational Control by MAPK Signaling in Long-Term Synaptic Plasticity and Memory , 2004, Cell.
[11] E. Capriotti,et al. Functional annotations improve the predictive score of human disease‐related mutations in proteins , 2009, Human mutation.
[12] Alcino J. Silva,et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 , 2002, Nature.
[13] Yoichi Matsubara,et al. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome , 2007, Journal of Medical Genetics.
[14] T. Südhof. Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.
[15] Y. Matsubara,et al. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders , 2008, Human mutation.
[16] Alcino J. Silva,et al. Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.
[17] Béatrice Conne,et al. The 3′ untranslated region of messenger RNA: A molecular ‘hotspot’ for pathology? , 2000, Nature Medicine.
[18] Huilin Li,et al. The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure , 2009, Cell.
[19] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[20] Thomas Bourgeron,et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. , 2010, Trends in genetics : TIG.
[21] A. Addington,et al. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. , 2009, The New England journal of medicine.
[22] R. Gibbs,et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders , 2011, Human molecular genetics.
[23] Thomas Bourgeron,et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.
[24] S. Spence,et al. The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. , 2001, American journal of human genetics.
[25] P. Worley,et al. Homer: a link between neural activity and glutamate receptor function , 2000, Current Opinion in Neurobiology.
[26] Kenny Q. Ye,et al. A unified genetic theory for sporadic and inherited autism , 2007, Proceedings of the National Academy of Sciences.
[27] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[28] M. Bear,et al. Extracellular Signal-Regulated Protein Kinase Activation Is Required for Metabotropic Glutamate Receptor-Dependent Long-Term Depression in Hippocampal Area CA1 , 2004, The Journal of Neuroscience.
[29] T. Shaikh,et al. Rare structural variation of synapse and neurotransmission genes in autism , 2011, Molecular Psychiatry.
[30] J. Sweatt,et al. Mitogen-activated protein kinases in synaptic plasticity and memory , 2004, Current Opinion in Neurobiology.
[31] Mark F. Bear,et al. Correction of Fragile X Syndrome in Mice , 2007, Neuron.
[32] Robert T. Schultz,et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes , 2009, Nature.
[33] Alan R. Mardinly,et al. The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc , 2010, Cell.
[34] M. State,et al. The genetics of autism: key issues, recent findings, and clinical implications. , 2010, The Psychiatric clinics of North America.
[35] B. Leventhal,et al. Autism and tuberous sclerosis , 1991, Journal of autism and developmental disorders.
[36] Gary D Bader,et al. Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.
[37] Mark F Bear,et al. The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.
[38] Kathryn Roeder,et al. Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.
[39] Guosong Liu,et al. Regulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer , 2001, Neuron.
[40] Anton J. Enright,et al. Human MicroRNA Targets , 2004, PLoS biology.
[41] Thomas Bourgeron,et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.
[42] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[43] M. Vihinen,et al. Performance of mutation pathogenicity prediction methods on missense variants , 2011, Human mutation.
[44] Danish Sayed,et al. MicroRNAs in development and disease. , 2011, Physiological reviews.
[45] Mark F. Bear,et al. The Autistic Neuron: Troubled Translation? , 2008, Cell.
[46] D. Geschwind,et al. Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.
[47] Thomas Bourgeron,et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.
[48] R. Huganir,et al. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[49] Predrag Radivojac,et al. Automated inference of molecular mechanisms of disease from amino acid substitutions , 2009, Bioinform..
[50] H. Zoghbi,et al. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes , 2008, Nature.
[51] Joshua M. Korn,et al. Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.
[52] Mark F Bear,et al. Toward fulfilling the promise of molecular medicine in fragile X syndrome. , 2011, Annual review of medicine.